Eli

Long ACAD above $30. Target 31 and 35 in January.

Eli Diupdate   
NASDAQ:ACAD   ACADIA Pharmaceuticals Inc.
4
ACAD in a money squeeze that appears to release soon to the upside coinciding with resistance break through. Daily MACD turned bullish and major MAs turning up. A good long idea upon confirmation of break out.
Trade aktif:
Breakout occurred and Price is back to the $30 breakout level, testing it as support. If support holds, go long still targeting $35. If support fails, 24 and 20 are downside targets.
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.